Phrenic nerve studies predict survival in amyotrophic lateral sclerosis

Area of Science:

• Neurology
• Respiratory Medicine
• Neurodegenerative Diseases

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by rapid progression and respiratory failure, leading to short survival times.
• Effective prognostic markers are crucial for managing ALS patients and guiding clinical decisions.

Purpose of the Study:

• To evaluate the predictive value of phrenic nerve motor response amplitude for survival in a large cohort of ALS patients.
• To identify key factors influencing survival in ALS, including disease onset and respiratory function.

Main Methods:

• A cohort of 254 ALS patients underwent phrenic nerve stimulation to measure motor response amplitude (PhrenAmpl).
• Data collected included demographics, onset region, diagnostic delay, forced vital capacity (FVC), and ALS functional rating scale (ALS-FRS).
• Survival analysis utilized Kaplan-Meier and Cox proportional hazards models.

Main Results:

• Small PhrenAmpl, bulbar onset, short diagnostic delay, and lower FVC were independently associated with reduced survival in the overall ALS population.
• Small PhrenAmpl and short diagnostic delay were significant negative predictors for both spinal and bulbar-onset ALS.
• Age at onset and FVC also independently predicted survival in bulbar-onset patients.

Conclusions:

• Phrenic nerve stimulation provides a rapid, non-volitional assessment and is a potent predictor of survival in ALS patients.
• This test should be integrated into routine respiratory assessments for individuals diagnosed with ALS to improve prognostic accuracy.